The numbers of intratumoral and stromal CD8+ and CD103+ tumor-infiltrating lymphocytes (TILs) according to patient clinicopathological characteristics in pulmonary squamous cell carcinoma cohort (n = 378). The gene discussed is CD8A; the disease is neoplasm.